Study Design and Methodology of Antibiotic Duration in Hematological Patients With <i>Pseudomonas aeruginosa</i> Bloodstream Infection-Reference-Cited by-同舟云学术

Study Design and Methodology of Antibiotic Duration in Hematological Patients With Pseudomonas aeruginosa Bloodstream Infection

Published:2024-05-29 Issue: Volume: Page:
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Feng Xiaomeng¹²,Qian Chenjing³,Fan Yuping¹²,Li Jia¹²,Wang Jieru¹²,Lin Qingsong¹²,Jiang Erlie¹²,Mi Yingchang¹²,Qiu Lugui¹²,Xiao Zhijian¹²,Wang Jianxiang¹²,Hong Mei³,Feng Sizhou¹²

Affiliation:

1. State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College , Tianjin , China

2. Tianjin Institutes of Health Science , Tianjin , China

3. Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology , Wuhan, Hubei , China

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciae148/58056369/ciae148.pdf

Reference8 articles.

1. Is short-course antibiotic therapy suitable for Pseudomonas aeruginosa bloodstream infections in onco-hematology patients with febrile neutropenia? Results of a multi-institutional analysis;Feng

2. Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer;Stern;Cochrane Database Syst Rev,2019

3. Short versus extended treatment with a carbapenem in patients with high-risk fever of unknown origin during neutropenia: a non-inferiority, open-label, multicentre, randomised trial;de Jonge;Lancet Haematol,2022